| |
| |
|
| Insider
Information: |
Middleton Fred A |
| Relationship: |
|
| City: |
San Mateo |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
593,164 |
|
|
Indirect Shares
|
7,544,680 |
|
|
| Direct
Value |
$2,890,947 |
|
|
|
Indirect Value
|
$5,837,433 |
|
|
| Total
Shares |
8,137,844 |
|
|
| Total
Value |
$8,728,380 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
9
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
7
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 0.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stereotaxis Inc |
STXS |
Director |
2018-03-02 |
303,528 |
2018-03-02 |
1,325,167 |
Premium* |
|
|
Mmrglobal Inc |
MMRF |
Director |
2008-12-09 |
0 |
2006-03-07 |
2,773,091 |
Premium* |
|
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Director |
2013-06-24 |
70,399 |
2013-06-24 |
0 |
Premium* |
|
|
Endocyte Inc |
ECYT |
Director |
2018-12-21 |
0 |
2018-12-21 |
0 |
Premium* |
|
|
Chimerix Inc |
CMRX |
Director |
2023-11-17 |
207,523 |
2023-11-17 |
3,407,954 |
Premium* |
|
|
Calcimedica Ord Shs |
CALC |
|
2024-01-23 |
11,714 |
2024-01-23 |
38,468 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
133 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ECYT |
Endocyte Inc |
Director |
– • – |
2011-12-19 |
4 |
B |
$3.13 |
$75,383 |
D/D |
24,084 |
74,084 |
2.39 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2014-03-13 |
4 |
S |
$4.20 |
$102,354 |
D/D |
(24,302) |
51,170 |
0 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2012-11-30 |
4 |
B |
$1.53 |
$37,271 |
D/D |
24,360 |
76,072 |
2.39 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
25,133 |
67,966 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • • |
2013-03-07 |
4/A |
S |
$25.92 |
$662,515 |
D/D |
(25,560) |
1,361,762 |
0 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • • |
2010-08-18 |
4 |
B |
$3.25 |
$84,500 |
D/D |
26,000 |
280,586 |
3.92 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2015-06-15 |
4 |
S |
$1.57 |
$40,920 |
I/I |
(26,064) |
1,107,189 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-06-18 |
4 |
AS |
$29.48 |
$872,608 |
I/I |
(29,600) |
145,298 |
0 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2017-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
119,682 |
0 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
149,682 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2019-05-10 |
4 |
B |
$2.92 |
$87,678 |
D/D |
30,000 |
97,523 |
2.39 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2019-11-13 |
4 |
B |
$1.82 |
$54,567 |
D/D |
30,000 |
147,523 |
2.39 |
- |
|
| MMRF |
Mmrglobal Inc |
Director |
– • – |
2007-11-02 |
4 |
B |
$0.00 |
$0 |
D/D |
35,149 |
116,678 |
2.31 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2004-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
37,718 |
140,947 |
|
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2015-06-08 |
4 |
S |
$1.60 |
$60,992 |
I/I |
(38,120) |
1,162,806 |
0 |
- |
|
| MMRF |
Mmrglobal Inc |
Director |
– • • |
2006-03-07 |
4 |
B |
$5.26 |
$250,003 |
D/D |
47,529 |
57,529 |
3.92 |
- |
|
| MMRF |
Mmrglobal Inc |
Director |
– • – |
2008-11-20 |
4 |
S |
$0.03 |
$1,226 |
D/D |
(47,529) |
0 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-06-19 |
4 |
AS |
$29.76 |
$1,440,384 |
I/I |
(48,400) |
96,898 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2011-12-16 |
4 |
B |
$3.16 |
$158,000 |
D/D |
50,000 |
50,000 |
2.39 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2020-03-12 |
4 |
B |
$1.40 |
$69,900 |
D/D |
50,000 |
197,523 |
2.39 |
% |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2015-06-05 |
4 |
S |
$1.69 |
$93,754 |
I/I |
(55,476) |
1,200,926 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-06-20 |
4 |
AS |
$28.93 |
$1,912,273 |
I/I |
(66,100) |
30,798 |
0 |
- |
|
| MMRF |
Mmrglobal Inc |
Director |
– • – |
2008-11-19 |
4 |
S |
$0.03 |
$1,902 |
D/D |
(69,149) |
47,529 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-06-21 |
4 |
AS |
$28.49 |
$2,041,714 |
I/I |
(70,000) |
5,900 |
0 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2004-12-15 |
4 |
D |
$0.00 |
$0 |
I/I |
(75,436) |
0 |
|
- |
|
133 Records found
|
|
Page 4 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
